메뉴 건너뛰기




Volumn 13, Issue 1, 2005, Pages 22-29

Mass uniformity: Influence of operational compression conditions of breakability of scored tablets as part of manufacturing robustness evaluation

Author keywords

Compression validation; Robustness development; Scored tablets; Statistical control; Tablet breakability; Weight uniformity

Indexed keywords

VETERINARY DRUG;

EID: 20344375236     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (27)
  • 2
    • 20344377282 scopus 로고    scopus 로고
    • Tablets
    • EDQM
    • EDQM. 2004. Tablets. Pharmeuropa 16: 250-253.
    • (2004) Pharmeuropa , vol.16 , pp. 250-253
  • 4
    • 20344405602 scopus 로고    scopus 로고
    • Variations: Guideline on dossier requirements for type IA and type IB notifications
    • EMEA
    • EMEA. 2003. Variations: guideline on dossier requirements for type IA and type IB notifications. Notice to Applicants. Vol. 2A. pp. 1-40.
    • (2003) Notice to Applicants , vol.2 A , pp. 1-40
  • 7
    • 20344406682 scopus 로고
    • Scoring configuration of generic drug products. MAPP5223.2
    • FDA. Office of Generic Drugs
    • FDA. 1995. Scoring configuration of generic drug products. MAPP5223.2. Office of Generic Drugs. pp. 1-4.
    • (1995) , pp. 1-4
  • 8
    • 20344388179 scopus 로고    scopus 로고
    • USP-NF. USP-NF Uniformity of Dosage Units (905)
    • USP-NF. 2004. Uniformity of Dosage Units, USP-NF (905).
    • (2004)
  • 9
    • 0036261861 scopus 로고    scopus 로고
    • The practice of splitting tablets: Cost and therapeutic aspects
    • Bachynsky, J., Wiens, C. and Melnychuk, K. 2002. The practice of splitting tablets: cost and therapeutic aspects. Pharmacoeconomics 20: 339-346.
    • (2002) Pharmacoeconomics , vol.20 , pp. 339-346
    • Bachynsky, J.1    Wiens, C.2    Melnychuk, K.3
  • 10
    • 0042162826 scopus 로고    scopus 로고
    • Patient experiences with the performance of tablet score lines needed for dosing
    • Rodenhuis, N., de Smet, P. A. and Barends, D. M. 2003. Patient experiences with the performance of tablet score lines needed for dosing. Pharm. World Sci. 25: 173-176.
    • (2003) Pharm. World Sci. , vol.25 , pp. 173-176
    • Rodenhuis, N.1    de Smet, P.A.2    Barends, D.M.3
  • 13
    • 0033862062 scopus 로고    scopus 로고
    • Effect of scoring design on the uniformity of extended release matrix tablet halves
    • Duman, E., Yuksel, N., Olin, B. and Sakr, A. 2000. Effect of scoring design on the uniformity of extended release matrix tablet halves. Pharm. Ind. 62: 547-550.
    • (2000) Pharm. Ind. , vol.62 , pp. 547-550
    • Duman, E.1    Yuksel, N.2    Olin, B.3    Sakr, A.4
  • 14
    • 0025944498 scopus 로고
    • The relationship between dividing properties of scored tablets and dynamic characteristics of powder
    • Ito, A. and Sugihara, M. 1991. The relationship between dividing properties of scored tablets and dynamic characteristics of powder. Yakugaku Zasshi 111: 606-611.
    • (1991) Yakugaku Zasshi , vol.111 , pp. 606-611
    • Ito, A.1    Sugihara, M.2
  • 15
    • 0026564239 scopus 로고
    • The effect of stationary time of punch in the process of compression on dividing properties of scored tablets
    • Ito, A., Dobashi, Y. and Sugihara, M. 1992. The effect of stationary time of punch in the process of compression on dividing properties of scored tablets. Yakugaku Zasshi 112: 757-762.
    • (1992) Yakugaku Zasshi , vol.112 , pp. 757-762
    • Ito, A.1    Dobashi, Y.2    Sugihara, M.3
  • 16
    • 0033775662 scopus 로고    scopus 로고
    • Dissolution characteristics of divisible tablets
    • Costa, P., Amaral, H. and Sousa Lobo, J. M. 2000. Dissolution characteristics of divisible tablets. STP Pharma Science 10: 373-377.
    • (2000) STP Pharma Science , vol.10 , pp. 373-377
    • Costa, P.1    Amaral, H.2    Sousa Lobo, J.M.3
  • 21
    • 20344381689 scopus 로고    scopus 로고
    • The use of scored tablets: Technical, clinical and pharmacoeconomic considerations
    • Submitted for publication in Annales Medicinae Militaris Belgicae
    • Lammens, G. and De Spiegeleer, B. 2004. The use of scored tablets: technical, clinical and pharmacoeconomic considerations. Submitted for publication in Annales Medicinae Militaris Belgicae.
    • (2004)
    • Lammens, G.1    De Spiegeleer, B.2
  • 23
    • 20344386104 scopus 로고
    • Pharmaceutical dosage forms: Tablets
    • Lieberman, L. A. and Lachman, L. eds. Marcel Dekker Inc. New York, U. S. A
    • Loeffler, G. F. 1981. Pharmaceutical dosage forms: tablets. In "Pharmaceutical Tablet Compression Tooling". pp. 451-484. Lieberman, L. A. and Lachman, L. eds. Marcel Dekker Inc. New York, U. S. A.
    • (1981) "Pharmaceutical Tablet Compression Tooling" , pp. 451-484
    • Loeffler, G.F.1
  • 24
    • 0014785506 scopus 로고
    • Determination of tablet strength by the diametral-compression test
    • Fell, J. T. and Newton, J. M. 1970. Determination of tablet strength by the diametral-compression test. J. Pharm. Sci. 59: 688-691.
    • (1970) J. Pharm. Sci. , vol.59 , pp. 688-691
    • Fell, J.T.1    Newton, J.M.2
  • 26
    • 0003139708 scopus 로고
    • Robust tests for equality of variance
    • Olkin, I., Ghurye, S. G., Hoeffding, W., Madow, W. G. and Mann, H. B. eds. Stanford University Press. California, U. S. A
    • Levene, H. 1960. Robust tests for equality of variance. Contributions to Probability and Statistics: Essays in honor of Harold Hotelling. pp. 278-292. Olkin, I., Ghurye, S. G., Hoeffding, W., Madow, W. G. and Mann, H. B. eds. Stanford University Press. California, U. S. A.
    • (1960) Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling , pp. 278-292
    • Levene, H.1
  • 27
    • 20344362080 scopus 로고    scopus 로고
    • Request for comments from industry on the application of the future harmonized Ph. Eur. Text "Uniformity of dosage units" to new and existing marketing authorizations
    • EMEA. CPMP/QWP/1526/04-EMEA/CVMP/483/04
    • EMEA. 2004. Request for comments from industry on the application of the future harmonized Ph. Eur. text "Uniformity of dosage units" to new and existing marketing authorizations. CPMP/QWP/1526/04-EMEA/CVMP/483/04.
    • (2004)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.